Inventor
YANG CHUNDAO
CN18 patents
⚠️ This page may combine multiple inventors who share the name “YANG CHUNDAO”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
MERCK SHARP & DOHME
6 patentsUS9718828B2Aug 1, 2017
BTK Inhibitors
MERCK SHARP & DOHME7 citations71
US9481682B2Nov 1, 2016
Substituted benzamides and substituted pyridinecarboxamides as Btk inhibitors
MERCK SHARP & DOHME2 citations51
US10087188B2Oct 2, 2018
Benzamide imidazopyrazine Btk inhibitors
MERCK SHARP & DOHME1 citations49
US9446130B2Sep 20, 2016
BTK inhibitors
MERCK SHARP & DOHME1 citations48
US10214546B2Feb 26, 2019
Btk inhibitors
MERCK SHARP & DOHME0 citations40
US10130630B2Nov 20, 2018
BTK inhibitors
MERCK SHARP & DOHME0 citations40
MEDSHINE DISCOVERY INC
4 patentsUS10532986B2Jan 14, 2020
Cyclic compound acting as PDE4 inhibitor
MEDSHINE DISCOVERY INC1 citations59
US11384065B2Jul 12, 2022
Heterocyclic compound as CSF-1R inhibitor and use thereof
MEDSHINE DISCOVERY INC0 citations51
US11299475B2Apr 12, 2022
Prostacyclin receptor agonist
MEDSHINE DISCOVERY INC0 citations51
US11230549B2Jan 25, 2022
Quinolino-pyrrolidin-2-one derivative and application thereof
MEDSHINE DISCOVERY INC0 citations50
WUXI BIOCITY BIOPHARMACEUTICS CO LTD
3 patentsUS11613545B2Mar 28, 2023
Macrocyclic compound serving as Wee1 inhibitor and applications thereof
WUXI BIOCITY BIOPHARMACEUTICS CO LTD2 citations71
US12291536B2May 6, 2025
Crystal form of Wee1 inhibitor compound and use thereof
WUXI BIOCITY BIOPHARMACEUTICS CO LTD0 citations50
US12180184B2Dec 31, 2024
Pyrimidopyrazolone derivative as Wee1 inhibitor and use thereof
WUXI BIOCITY BIOPHARMACEUTICS CO LTD0 citations50